Literature DB >> 29947938

[Imaging in acute ischemic stroke using automated postprocessing algorithms].

K Egger1, C Strecker2, E Kellner3, H Urbach4.   

Abstract

There are several automated analytical methods to detect thromboembolic vascular occlusions, the infarct core and the potential infarct-endangered tissue (tissue at risk) by means of multimodal computed tomography (CT) and magnetic resonance imaging (MRI). The infarct core is more reliably visualized by diffusion-weighted imaging (DWI) MRI or CT perfusion than by native CT. The extent of tissue at risk and endangerment can only be estimated; however, it seems essential whether "tissue at risk" actually exists. To ensure consistent patient care, uniform imaging protocols should be acquired in the referring hospital and thrombectomy center and the collected data should be standardized and automatically evaluated and presented. Whether patients with a large infarct core and with or without tissue at risk or patients with large vessel occlusion (LVO) but low NIHSS benefit from thrombectomy has to be evaluated in controlled clinical trials using standardized imaging protocols. A promising, potentially time-saving approach is also native CT and CT angiography using a flat-panel detector angiography system for assessment of vessel occlusion and leptomeningeal collaterals.

Entities:  

Keywords:  Imaging protocols; Infarct classification; Infarct core; Perfusion; Tissue at risk

Mesh:

Year:  2018        PMID: 29947938     DOI: 10.1007/s00115-018-0535-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  67 in total

1.  Perfusion CT in acute ischemic stroke: a qualitative and quantitative comparison of deconvolution and maximum slope approach.

Authors:  B Abels; E Klotz; B F Tomandl; S P Kloska; M M Lell
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-25       Impact factor: 3.825

2.  RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study.

Authors:  Maarten G Lansberg; Jun Lee; Soren Christensen; Matus Straka; Deidre A De Silva; Michael Mlynash; Bruce C Campbell; Roland Bammer; Jean-Marc Olivot; Patricia Desmond; Stephen M Davis; Geoffrey A Donnan; Gregory W Albers
Journal:  Stroke       Date:  2011-04-14       Impact factor: 7.914

3.  Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke.

Authors:  Bijoy K Menon; Christopher D d'Esterre; Emmad M Qazi; Mohammed Almekhlafi; Leszek Hahn; Andrew M Demchuk; Mayank Goyal
Journal:  Radiology       Date:  2015-01-29       Impact factor: 11.105

4.  Predictive Value of RAPID Assessed Perfusion Thresholds on Final Infarct Volume in SWIFT PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment).

Authors:  Maxim Mokin; Elad I Levy; Jeffrey L Saver; Adnan H Siddiqui; Mayank Goyal; Alain Bonafé; Christophe Cognard; Reza Jahan; Gregory W Albers
Journal:  Stroke       Date:  2017-03-10       Impact factor: 7.914

5.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.

Authors:  Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin
Journal:  Lancet       Date:  2016-02-18       Impact factor: 79.321

6.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

7.  Successful Reperfusion With Mechanical Thrombectomy Is Associated With Reduced Disability and Mortality in Patients With Pretreatment Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score ≤6.

Authors:  Jean-Philippe Desilles; Arthuro Consoli; Hocine Redjem; Oguzhan Coskun; Gabriele Ciccio; Stanislas Smajda; Julien Labreuche; Cristian Preda; Clara Ruiz Guerrero; Jean-Pierre Decroix; Georges Rodesch; Mikael Mazighi; Raphaël Blanc; Michel Piotin; Bertrand Lapergue
Journal:  Stroke       Date:  2017-02-24       Impact factor: 7.914

8.  Clinical Imaging Factors Associated With Infarct Progression in Patients With Ischemic Stroke During Transfer for Mechanical Thrombectomy.

Authors:  Gregoire Boulouis; Arne Lauer; Ahmer Khawdja Siddiqui; Andreas Charidimou; Robert W Regenhardt; Anand Viswanathan; Natalia Rost; Thabele M Leslie-Mazwi; Lee H Schwamm
Journal:  JAMA Neurol       Date:  2017-11-01       Impact factor: 18.302

9.  Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients.

Authors:  J-M Olivot; M Mlynash; G Zaharchuk; M Straka; R Bammer; N Schwartz; M G Lansberg; M E Moseley; G W Albers
Journal:  Neurology       Date:  2009-03-31       Impact factor: 9.910

10.  Facing the Time Window in Acute Ischemic Stroke: The Infarct Core.

Authors:  C J Maurer; K Egger; A-K Dempfle; M Reinhard; S Meckel; H Urbach
Journal:  Clin Neuroradiol       Date:  2016-02-04       Impact factor: 3.649

View more
  1 in total

1.  [Big data and artificial intelligence].

Authors:  Frank Schneider; Cornelius Weiller
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.